People In The News: Topside Changes At Oxygen Biotherapeutics, EMD Serono And Volatarr; CMS’s Shrank Lands At CVS Caremark
Executive Summary
Oxygen Biotherapeutics names John Kelley CEO following acquisition of Phyxius Pharma; former director at CMS innovation center William Shrank named CSO, CMO at CVS Caremark; Paris Panayiotopoulos moves from president role at Merck Serono to same title at EMD Serono; more personnel announcements in this month’s column.